These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22908102)

  • 21. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.
    Domínguez A; Torner N; Barrabeig I; Rovira A; Rius C; Cayla J; Plasencia E; Minguell S; Sala MR; Martínez A; Costa J; Mosquera M; Cabezas C;
    Clin Infect Dis; 2008 Nov; 47(9):1143-9. PubMed ID: 18823269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles control in a rural area in Zimbabwe.
    Tumwine JK
    East Afr Med J; 1991 Sep; 68(9):694-701. PubMed ID: 1797531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Widespread outbreaks of measles in rural Uttar Pradesh, India, 1996: high risk areas and groups.
    Singh J; Kumar A; Rai RN; Khare S; Jain DC; Bhatia R; Datta KK
    Indian Pediatr; 1999 Mar; 36(3):249-56. PubMed ID: 10713838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guidelines for vaccination against measles in children].
    Avila-Figueroa C; Navarrete-Navarro S; Santos JI
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):528-33. PubMed ID: 2206422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles vaccine coverage and factors related to uncompleted vaccination among 18-month-old and 36-month-old children in Kyoto, Japan.
    Matsumura T; Nakayama T; Okamoto S; Ito H
    BMC Public Health; 2005 Jun; 5():59. PubMed ID: 15935101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two doses of measles vaccine reduce measles dealths.
    van den Ent M; Gupta SK; Hoekstra E
    Indian Pediatr; 2009 Nov; 46(11):933-8. PubMed ID: 19955576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination vaccine use and vaccination quality in a managed care population.
    Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
    Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles transmission following the tsunami in a population with a high one-dose vaccination coverage, Tamil Nadu, India 2004-2005.
    Mohan A; Murhekar MV; Wairgkar NS; Hutin YJ; Gupte MD
    BMC Infect Dis; 2006 Sep; 6():143. PubMed ID: 16984629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection after two doses of measles vaccine is independent of interval between doses.
    De Serres G; Sciberras J; Naus M; Boulianne N; Duval B; Rochette L
    J Infect Dis; 1999 Jul; 180(1):187-90. PubMed ID: 10353877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles vaccination coverage, determinants of delayed vaccination and reasons for non-vaccination among children aged 24-35 months in Zhejiang province, China.
    Hu Y; Wang Y; Chen Y; Liang H; Chen Z
    BMC Public Health; 2018 Nov; 18(1):1298. PubMed ID: 30482185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.